Skip Navigation LinksHome > February 2011 - Volume 30 - Issue 2 > SEVERE PERTUSSIS IN INFANTS: ESTIMATED IMPACT OF FIRST VACCI...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0b013e3181f43906
Brief Reports

SEVERE PERTUSSIS IN INFANTS: ESTIMATED IMPACT OF FIRST VACCINE DOSE AT 6 VERSUS 8 WEEKS IN AUSTRALIA

Foxwell, Alice Ruth MSc, PhD*†; McIntyre, Peter MB BS, PhD‡; Quinn, Helen MAE, PhD‡; Roper, Katrina MAE, PhD*; Clements, Mark S. PhD†

Collapse Box

Abstract

We estimated the potential benefits of advancing the first dose of pertussis vaccine for infants from 8 to 6 weeks of age, using Australian national disease databases. Infants had notification rates 3-fold greater than the general population and accounted for 52% of recorded hospitalizations. Infants 1 and 2 months of age had notification rates 3.5 times (95% CI: 2.7–4.5) higher than infants 3 to 11 months of age. Estimation of acceleration of the vaccine to 6 weeks of age reduced average notifications, hospitalizations, and hospital bed-days by 8%, 9%, and 12%, respectively, with larger reductions in an epidemic year.

© 2011 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.